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Summary
Translation and mRNA degradation are affected by a
key transition where eukaryotic mRNAs exit transla-
tion and assemble an mRNP state that accumulates
into processing bodies (P bodies), cytoplasmic sites
of mRNA degradation containing nontranslating mRNAs,
and mRNA degradation machinery. We identify the
decapping activators Dhh1p and Pat1p as functioning
as translational repressors and facilitators of P body
formation. Strains lacking both Dhh1p and Pat1p
show strong defects in mRNA decapping and P body
formation and are blocked in translational repression.
Contrastingly, overexpression of Dhh1p or Pat1p
causes translational repression, P body formation,
and arrests cell growth. Dhh1p, and its human homo-
log, RCK/p54, repress translation in vitro, and Dhh1p
function is bypassed in vivo by inhibition of trans-
lational initiation. These results identify a broadly
acting mechanism of translational repression that tar-
gets mRNAs for decapping and functions in transla-
tional control. We propose this mechanism is compet-
itively balanced with translation, and shifting this
balance is an important basis of translational control.
Introduction
A key aspect of the regulation of eukaryotic gene ex-
pression is control of mRNA translation and degrada-
tion. A major pathway of mRNA decay in eukaryotes is
initiated by shortening of the 3# poly(A) tail (deadeny-
lation), followed by cleavage of the 5# m7GpppN cap
(decapping), and ultimately, 5# to 3# exonucleolytic
degradation (for review, see Coller and Parker, 2004).
Decapping is a critical step in this decay pathway as it
permits destruction of the mRNA body and is a site of
numerous control inputs. Translation and mRNA decap-
ping are intertwined. For example, decreasing transla-
tion initiation by a variety of means increases the rate
of decapping. Conversely, inhibition of translation elon-
gation significantly decreases the rate of decapping
(Coller and Parker, 2004). Moreover, translation initia-
tion factors such as the cap binding protein eIF-4E can
directly inhibit decapping, and thus before an mRNA
undergoes decapping, it exits translation by an un-
known mechanism wherein translational initiation fac-
tors dissociate from the transcript, and an mRNA de-*Correspondence: rrparker@u.arizona.edu
2Present address: Center for RNA Molecular Biology, Case West-
ern Reserve University, 10900 Euclid Avenue, Cleveland, Ohio
44106.capping complex assembles on the mRNA (Schwartz
and Parker, 1999, 2000; Tharun and Parker, 2001).
The requirement for exiting translation prior to de-
capping implies that there is a general, and unknown,
process by which the vast majority of mRNAs can exit
translation and enter a translationally inactive state. In
principle, exiting of mRNAs from translation could sim-
ply be a passive process occurring in the absence of
ongoing recruitment of the translational apparatus. In
this view, translational repression would occur as a de-
fault state. Alternatively, and more consistent with mRNA
decapping being a regulated process, the cell may pos-
sess a general mechanism for actively targeting mRNAs
into a translationally repressed state.
Evidence suggesting cells might have a general
mechanism for translational repression comes from the
observation that mRNAs that have exited translation
and can be targeted for decapping, accumulate within
discrete cytoplasmic foci, referred to as P bodies (also
referred to as GW182 or DCP bodies). P bodies are dy-
namic RNA-protein aggregates containing untranslated
mRNAs, the decapping machinery (Bashkirov et al.,
1997; Ingelfinger et al., 2002; Lykke-Andersen, 2002;
Van Dijk et al., 2002; Teixeira et al., 2005), and are sites
where decapping can occur (Sheth and Parker, 2003;
Cougot et al., 2004). This suggests that when mRNAs
exit translation, they assemble an mRNP complex con-
taining the decapping machinery, which can then un-
dergo either decapping, or aggregation into P bodies.
It is currently unclear whether assembly of individual
mRNPs into a larger P body structure directly affects
the rate of decapping or plays a different role in control
of mRNA function.
An important and unresolved issue is the manner by
which mRNAs exit translation and are targeted for de-
capping and accumulation in P bodies. Moreover, be-
cause P bodies increase under conditions that globally
repress translation, it is possible that the mechanism
that targets mRNAs for decapping and P body accumu-
lation might also play an important role in the control
of translation, both globally and on specific mRNAs.
Given the intertwined nature of mRNA decapping and
translation, we hypothesized that a subset of the pro-
teins involved in decapping may function by promoting
translational repression. Indeed, several observations
led us to hypothesize that the decapping activators,
Dhh1p, and Pat1p might function in the pathway of
moving mRNAs from polysomes and into the transla-
tionally inert state that accumulates in P bodies. First,
both proteins show genetic interactions with translation
initiation factors (Bonnerot et al., 2000; Wyers et al.,
2000; Coller et al., 2001). Second, Pat1p coimmuno-
precipitates with Pab1p and eIF-4E in an RNA-depen-
dent manner (Tharun and Parker, 2001), suggesting that
Pat1p can interact with the transcript while it is still
translationally competent. Third, two homologs of
Dhh1p, Me31b in Drosophila and the Xenopus protein
Xp54, function in translational control of metazoan ma-
ternal mRNAs (Ladomery et al., 1997; Minshall et al.,
2001; Nakamura et al., 2001). Finally, because strains
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876lacking Dhh1p or Pat1p each show partial defects in
mRNA decapping, we hypothesized that these proteins
might work independently to repress translation, thereby
activating decapping and P body formation.
In this work, we tested this hypothesis by examining
the functions of Dhh1p and Pat1p with respect to
mRNA decay, P body formation, and translational re-
pression. Our results indicate that Dhh1p and Pat1p
function as a general and active mechanism of transla-
tional repression, which functions independent of the
cap structure and can also repress translation from a
broad spectrum of IRES elements. This translational re-
pression machinery targets mRNAs for decapping, fa-
cilitates their assembly into P bodies, and appears to
be conserved throughout eukaryotes. Importantly, these
results indicate that a general translation repression
machinery exists within cells that is in constant com-
petition with the translation apparatus and that the
balance of this competition provides the basis for
translational repression that occurs under numerous
biological contexts.
Results
Dhh1p and Pat1p Have Additive Effects
on mRNA Decay
As discussed above, we hypothesized that the decap-
ping regulators, Dhh1p, and Pat1p might function inde-
pendently in the pathway of moving mRNAs from poly-
somes and into the translationally inert state that
accumulates in P bodies. To test this hypothesis, we
first examined the phenotypes of dhh1D, pat1D, and
dhh1D/pat1D double mutants, with respect to mRNA
decay, P body formation, and translational repression.
In addition, because the Lsm1-7p complex can also
promote mRNA decapping, we examined the effects of
combining a lsm1D, which inactivates the Lsm1-7p
complexes function in mRNA decapping, with the
pat1D and dhh1D lesions.
The effect of each mutant background on decapping
was determined by using a transcriptional shut-off
strategy for the MFA2pG reporter gene, which is under
the control of the GAL promoter, thereby allowing re-
pression of transcription by addition of glucose (Muhl-
rad et al., 1994). In addition, the MFA2pG gene contains
a polyguanosine tract (pG) in its 3#UTR that blocks 5#
to 3# exonuclease digestion and thereby traps an inter-
mediate in mRNA degradation (Muhlrad et al., 1994).
We observed that dhh1D/pat1D double mutants had
a severe block to mRNA decapping, stronger than
either dhh1D or pat1D single mutants. Specifically, fol-
lowing glucose repression of transcription, decay rate
of the MFA2pG mRNA is slowed in dhh1D (t1/2 = 12#;
Figure S1B in the Supplemental Data available with this
article online) or pat1D (t1/2 = 15#; Figure S1C) com-
pared to wild-type (WT) (t1/2 = 5#; Figure S1A), whereas
the dhh1D/pat1D strain shows an even slower decay
rate (t1/2 = 26#; Figure S1D). Accumulation of stable,
deadenylated mRNAs in dhh1D/pat1D indicates a sig-
nificant defect in mRNA decapping (Figure S1D), con-
sistent with the partial block to decapping observed in
dhh1D or pat1D single mutants (Coller et al., 2001,
Fischer and Weis, 2002; Tharun et al., 2000; Bouveret
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bt al., 2000). In contrast, a pat1D/lsm1D strain behaved
imilar to a pat1D or lsm1D strain (Figure S1F). This is
onsistent with other results arguing that the Lsm1-7p
omplex and Pat1p work together to promote mRNA
ecapping (Bouveret et al., 2000). Thus, a dhh1D/lsm1D
train showed an additive effect on mRNA decay but
ot as strong as dhh1D/ pat1D (Figure S1G and data
ot shown). These results suggest that Dhh1p and
at1p can function independently, but at a similar step,
n promoting mRNA decapping.
hh1p and Pat1p Have Additive Effects
n P Body Formation
bodies are cytoplasmic foci within which mRNA de-
apping can occur and presumably reflect formation of
n mRNP state that has undergone translational repres-
ion and is capable of decapping (Sheth and Parker,
003; Cougot et al., 2004; Teixeira et al., 2005). Their
ize and abundance is proportional to the pool of un-
ranslating mRNAs, which can be substrates for the de-
apping reaction. Therefore, P body formation can be
sed as a microscopic assay for monitoring the flux
f mRNA through different stages of the decapping
athway.
The strong block to mRNA decapping seen in dhh1D/
at1D could be a result of either an inability to exit
ranslation and thus access the decapping machinery
decreasing P body abundance) or an inability to be
rocessed by the decapping enzyme (increasing P
ody abundance). To distinguish between these two
ossibilities, we monitored P body formation in dhh1D,
at1D, and dhh1D/pat1D strains under glucose depri-
ation, which stimulates P body formation (Teixeira et
l., 2005). Visualization of P bodies was achieved using
GFP fusion protein of the decapping enzyme Dcp2p
Bashkirov et al., 1997; Ingelfinger et al., 2002; Lykke-
ndersen, 2002; Van Dijk et al., 2002; Sheth and Parker,
003). In WT cells, P bodies are seen in nearly all cells
isualized, with 1–4 foci per cell (Figure 1A, panel i). In
oth dhh1D and pat1D, the number of P bodies did not
hange significantly (Figure 1A, panel ii and iii). How-
ver, in dhh1D/pat1D, less than 10% of cells contained
bodies (Figure 1A, panel iv). This is in contrast to a
cp1D strain, which lacks a component of the decap-
ing enzyme, thus inhibiting the decapping reaction di-
ectly and causing P bodies to accumulate (Sheth and
arker, 2003) (Figure 1A, panel v). These strains all con-
ained similar levels of the Dcp2p-GFP protein, indicat-
ng that differences in P body abundance were not due
o decreased expression of the fusion protein (Figure
2A). Additionally, changes in P body size and abun-
ance are not reflective of growth rate differences as
hh1D/pat1D grows similarly to the dcp1D strain. Fur-
hermore, similar results were obtained by monitoring
bodies using a GFP fusion to Lsm1p (Figure S3). To-
ether, these results argue that Dhh1p and Pat1p act
t an early step in mRNA decay prior to P body forma-
ion. Since translational repression is a key step in pro-
oting mRNA decapping (Schwartz and Parker, 1999,
000) and P bodies contain pools of nontranslating
RNPs (Sheth and Parker, 2003; Teixeira et al., 2005),
e hypothesized that Dhh1p and Pat1p might function
o repress translation of mRNAs, thereby promoting P
ody formation.
A Mechanism of General Translational Repression
877Figure 1. Dhh1p and Pat1p Have Additive Effects on P Body Formation and Are Required for Translational Repression
(A) Using Dcp2p-GFP as a marker, P bodies were observed in wild-type (WT), dhh1D, pat1D, dhh1D/pat1D, or dcp1D strains.
(B) Depicted are polysome profiles (OD260nm traces) of WT, dhh1D, pat1D, dhh1D/pat1D, or dcp1D before and after glucose deprivation. The
nontranslating region (RNP), 80S monosome (80S), and polysomes (P) are indicated above.
(C) Northern of RPL41a mRNA following polysome analysis in WT or dhh1D/pat1D before and after glucose deprivation.
(D) Incorporation of [35S]methionine in WT and dhh1D/pat1D cells before and after glucose deprivation. Values are reported as cpm incorpo-
rated. Time after label addition indicated.
(E) Polysome profiles (OD260nm traces) of WT and dhh1D/pat1D strains before and after amino acid deprivation.Dhh1p or Pat1p Is Required
for Translational Repression
To determine if Dhh1p and Pat1p function in transla-
tional repression, we examined the cell’s response to
glucose deprivation. In yeast, glucose deprivation
leads to repression of protein synthesis by an unknown
mechanism (Ashe et al., 2000) and increases P body
size and abundance (Teixeira et al., 2005). If Dhh1p and
Pat1p function to move mRNAs out of polysomes,
thereby allowing P body assembly, then dhh1D/pat1Dcells would be unable to repress translation in response
to a physiological cue.
WT, dhh1D, pat1D, and dhh1D/pat1D strains were
grown in the presence of glucose until reaching mid-
log phase. Cultures were shifted to media lacking glu-
cose for 10 min and then examined for translational re-
pression by polysome analysis. Consistent with earlier
work, glucose depletion led to a rapid loss of poly-
somes in WT cells (Ashe et al., 2000) (Figure 1B). In a
dhh1D or pat1D mutant, the ability to undergo transla-
Cell
878tional repression is only slightly impaired (Holmes et al.,
2004) (Figure 1B). In contrast, translation is no longer
repressed in the dhh1D/pat1D mutant upon glucose
deprivation (Figure 1B). Consistent with this global
analysis, specific mRNAs are moved from polysomes
into the mRNP fraction in WT cells but retained on poly-
somes in dhh1D/pat1D following glucose repression
(Figure 1C). Moreover, translation rate as measured by
[35S]methionine incorporation is not significantly re-
duced in dhh1D/pat1D as compared to WT following
glucose depletion (Figure 1D). These results demon-
strate that either Dhh1p or Pat1p are required for the
general translational repression that occurs upon glu-
cose deprivation. Moreover, we observed that dhh1D/
pat1D were unable to repress translation in response to
amino acid starvation (Figure 1E). These observations
indicate that Dhh1p or Pat1p are required for global
translational repression in a variety of biological con-
texts. A role of Dhh1p and Pat1p in promoting transla-
tional repression is consistent with the observation that
dhh1D/pat1D cells have severe defects in both mRNA
decapping and P body formation.
Previous results have demonstrated that dcp1D,
dcp2D, and xrn1D strains are also defective in transla-
tional repression in response to glucose deprivation
(Figure 1B) (Holmes et al., 2004). Several observations
suggest that this is an indirect effect of sequestering
Dhh1p and Pat1p in P bodies. First, unlike dhh1D/
pat1D mutants, dcp1D, dcp2D, and xrn1D cells contain
high levels of P bodies, which contain Dhh1p and Pat1p
(Sheth and Parker, 2003; Teixeira et al., 2005) (Figure 1A
panel iv versus panel v). Second, in contrast to Dhh1p
and Pat1p, overexpression of Dcp1p or Dcp2p does not
repress mRNA translation (see below). Third, overex-
pression of either Dhh1p or Pat1p restores translational
repression in dcp1D, and dcp2D strains (see below and
data not shown).
Overexpression of Either Dhh1p or Pat1p Drives
Translational Repression and P Body Formation
Additional evidence that Dhh1p and Pat1p function to
repress translation was obtained from analyzing the ef-
fects of overexpression of either Dhh1p or Pat1p from
an inducible galactose promoter in WT cells. First, over-
expression of Dhh1p or Pat1p, but not Dcp1p, Dcp2p,
or Edc3p, inhibits cell growth (Figure 2E). Second, over-
expression of either Dhh1p or Pat1p, but not Dcp1p,
dramatically reduced polysomes and resulted in a con-
comitant increase in P body abundance (Figure 2A).
Third, overexpression of either Dhh1p or Pat1p reduced
the rate of translation as indicated by a decrease in
[35S]methionine incorporation (Figure 2B). Finally, over-
expression of either Dhh1p or Pat1p caused relocation
of the PGK1, RPL41a, COX17, TIF51a, and CYH2
mRNAs from heavy polysomes to the mRNP region of
the density gradient (Figure 2C and data not shown),
where components of P bodies, such as Dhh1p (Figure
2D), Pat1p, Lsm1p, and Dcp1p are seen to migrate
(Bonnerot et al., 2000). These results provide a second
line of evidence that Dhh1p and Pat1p function to pro-
mote disassociation of mRNA from polysomes and thus
facilitate assembly of mRNAs into P bodies. Interest-
ingly, overexpression of either Dhh1p or Pat1p had no
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wffect on the steady-state abundance of mRNA (Figure
4). This suggests that following Dhh1p and/or Pat1p
unction, there is an additional limiting step after as-
embly of a P body that is required to dictate mRNA
ecay.
hh1p and Pat1p Stimulate Translational Repression
nd P Body Formation Independently
o determine the basis for the overexpression lethality
nd the interrelationship of Dhh1p and Pat1p function,
e examined the consequences of overexpression of
ither protein in strains lacking other components of P
odies. Overexpression of Dhh1p or Pat1p still inhibited
rowth in strains lacking Dcp1p, Dcp2p, and Lsm1p
Figure 3A). As strains lacking Dcp1p or Dcp2p are
locked for decapping, this indicates that overexpres-
ion lethality does not require mRNA decapping. Impor-
antly, we observed that overexpression of Dhh1p in
at1D cells or overexpression of Pat1p in dhh1D cells
till resulted in inhibition of cell growth, decreased poly-
omes, and increased P body abundance (Figures 3A–
C). These results indicate that Pat1p and Dhh1p stim-
late translational repression in yeast independently,
onsistent with the observations that Dhh1p and Pat1p
ave additive effects on turnover, P body formation,
nd translational repression.
hh1p and Its Human Homolog RCK/p54 Repress
RNA Translation In Vitro
he above results document that Dhh1p and Pat1p
unction in vivo to repress translation, thereby allowing
hem to assemble into the translational inactive state
hat can accumulate within P bodies. To determine if
hh1p directly represses translation, we asked if re-
ombinant Dhh1p could repress translation in vitro. In
hese experiments, we added purified GST-Dhh1p to
east and rabbit reticulocyte extracts programmed with
luciferase reporter (LUC) in vitro and assayed transla-
ion by monitoring LUC activity. We analyzed transla-
ion in both yeast and mammalian systems because we
nticipated that any function of Dhh1p in repressing
ranslation would be conserved. This hypothesis is
upported by the observations that Dhh1p is highly
onserved, vertebrate homologs can complement a
east dhh1D strain, and overexpression of the mamma-
ian homolog, RCK/p54, in tissue culture cells represses
rowth (Tseng-Rogenski et al., 2003; Westmoreland et
l., 2003; Akao et al., 1998). We focused on Dhh1p in
hese experiments because it is more conserved than
at1p, and recombinant Pat1p has been difficult to pu-
ify to date.
Addition of recombinant Dhh1p repressed translation
n a dose-dependent manner in both yeast and rabbit
eticulocyte extracts (Figure 4A). Importantly, these re-
ults were not due to destabilization of the LUC repor-
er mRNA in either system (Figure 4A and data not
hown). Furthermore, by using mutant alleles of Dhh1p,
e demonstrated that repression of translation in vitro
s similar to Dhh1p function in vivo. For example, the
ecombinant mutant protein, Dhh1-8p, was unable to
timulate translational repression in either yeast or
eticulocyte extracts (Figure 4C). The dhh1-8 allele,
hich has alanine substitutions of Arg 345 and Gly 346,
A Mechanism of General Translational Repression
879Figure 2. Overexpression of Dhh1p or Pat1p Causes General Translational Repression and Increases P Bodies
(A) Polysome profiles and P body accumulation in control cells (vector) or cells overexpressing Dhh1p, Pat1p, or Dcp1p. Times after induction
by the addition of galactose are indicated. P bodies were visualized using Dcp2p-GFP.
(B) Incorporation of [35S]methionine in cells overexpressing Dhh1p, Pat1p, or a vector control. Values are reported as cpm incorporated. Time
after addition of label indicated.
(C) Northerns of the PGK1 and RPL41a mRNA following polysome analysis, in control cells, or cells overexpressing Dhh1p or Pat1p. Minutes
after induction are indicated. Nontranslating (RNP) and translating areas (polysomes) are indicated above.
(D) Western analysis indicating location of Dhh1p on a sucrose gradient.
(E) Growth of yeast cells when Dhh1p, Pat1p, Dcp1p, Dcp2p, or Edc3p are overexpressed. Cells were plated on either glucose media,
or galactose.
Cell
880Figure 3. Dhh1p and Pat1p Stimulate Translational Repression via
Parallel Pathways
(A) Shown is growth of yeast cells when Dhh1p or Pat1p are over-
expressed in strains deleted for components of P bodies. Cells
were plated on glucose media or galactose media.
(B) Polysome and P body analysis of cells overexpressing Dhh1p
in a pat1D strain or (C) Pat1p in a dhh1D strain. Nontranslating
region (RNP), 80S monosome (80S), and polysomes (P) are indi-
cated above first trace. P bodies were visualized using Dcp2p-GFP.
Time after galactose induction is indicated.
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4prevents a required conformational rearrangement in
Dhh1p, thus inhibiting Dhh1p’s function in decapping
in vivo (Cheng et al., 2005). Importantly, overexpression
of Dhh1-8p in vivo is unable to induce translational re-
pression (Figure S5). Similar effects were seen for addi-
tional mutant forms of Dhh1p, such as the dhh1-2 allele
(D195A, E196A), which is predicted to be unable to hy-
drolyze ATP, and is null for function in vivo (Cheng et
al., 2005 and data not shown). Moreover, inhibition of
translation is specific to Dhh1p activity because addi-
tion of recombinant Ded1p, an ATP-dependent helicase
with similarity to Dhh1p, stimulated rather than re-
pressed translation in both yeast and reticulocyte ex-
tracts (Figure 4B).
The ability of Dhh1p to repress translation in both
yeast and mammalian cell extracts suggested that this
function would be conserved in its homologs. To test
this prediction, we purified the human homolog of
Dhh1p, termed RCK/p54, and examined if it could re-
press translation in vitro. Similar to Dhh1p, recombinant
RCK/p54 repressed LUC translation in a dose-depen-
dent manner (Figure 4D). These results demonstrate
that Dhh1p can directly repress translation and this
function is conserved from yeast to mammals.
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chh1p Inhibits the Production of a Stable 48S
reinitiation Complex
ecapitulation of Dhh1p-dependent translational re-
ression in vitro facilitated examination of the mecha-
ism by which Dhh1p affects translation. Translational
nitiation can be divided into three broad steps. First,
IF-4F recognizes and binds the 5#-cap structure. Sec-
nd, eIF-4F, with eIF3, recruits 43S preinitiation com-
lex (consisting of the 40S ribosome, eIF2, GTP, and
et-tRNAi), leading to formation of a 48S preinitiation
omplex. Third, 48S complex recognizes the AUG, at
hich point GTP is hydrolyzed and the 60S ribosomal
ubunit joins, initiating polypeptide synthesis.
It has previously been proposed that Dhh1p might
ct to dissociate eIF-4E from the 5#-cap structure and
hereby promote decapping (Fischer and Weis, 2002).
uch a mode of function could also explain Dhh1p’s
nhibition of translation. If Dhh1p acts to dissociate eIF-
E from the cap structure than Dhh1p would be pre-
icted to have no effect on the translation of uncapped
RNAs. However, we observed that both Dhh1p and
CK/p54 were equally effective at repressing the trans-
ation of both capped and uncapped mRNAs (Figure 4E
nd data not shown). This argues that Dhh1p inhibits a
tep in translation independent of cap recognition.
To determine if Dhh1p affects a step upstream of for-
ation of 48S preinitiation complex, translation ex-
racts were programmed with radiolabeled mRNA with
r without Dhh1p and in the presence of various trans-
ational inhibitors. Use of substeps specific inhibitors
llows translational initiation to be studied by trapping
ynamic intermediates (Gray and Hentze, 1994). Accu-
ulation of initiation complexes was monitored by
ucrose density gradient sedimentation and quantifica-
ion of labeled mRNA following fractionation. In WT cells,
ddition of a nonhydrolysable GTP analog (GMPPNP)
locks 60S subunit joining causing accumulation of
8S preinitiation complex (Figure 4F) (Gray and Hentze,
994). Strikingly, addition of purified Dhh1p eliminated
ccumulation of 48S preinitiation complex (Figure 4F).
his result suggests that Dhh1p represses translation
n vitro by inhibiting the ability of 48S complex to form
n mRNA. These effects may be a direct consequence
f Dhh1p acting upstream of 48S formation, acting on
he 48S complex itself, or via promotion of assembly of
repression complex that is independent of transla-
ional initiation factors.
road Spectrum Inhibition of mRNA Translation
y Dhh1p and RCK/p54
o determine if Dhh1p or RCK/p54 affect a specific step
n translation initiation or were broadly acting general
ranslational repressors, we examined their effect on
ranslational initiation driven by various internal ribo-
omal entry sites (IRES). IRES elements allow transla-
ional initiation in a manner independent of subsets of
ranslation initiation factors (Figure 5A). This allows
ranslation inhibitors that act on discrete translational
nitiation factors to have their site of action identified
Ostareck et al., 2001). We focused on RCK/p54 for
hese experiments as IRES elements function more effi-
iently in mammalian systems and used IRES elements
A Mechanism of General Translational Repression
881Figure 4. Dhh1p and Its Human Homolog RCK/p54 Stimulate Translational Repression In Vitro
(A) GST-Dhh1p, (B) GST-Ded1p, (C) GST-Dhh1-8p, or (D) His-RCK/p54 was added to either yeast or reticulocyte extracts. LUC activity normal-
ized to translation observed in absence of test protein. Protein concentration is indicated below graph. For (C), 7.3 M of protein was added.
Northern of LUC reporter from extracts containing Dhh1p (A) or RCK/p54 (D).
(E) Graph indicates relative LUC activity of cap plus (Cap+Luc) and cap minus (Luc) LUC reporter in the presence of buffer, 1.0 M GST-
Dhh1p, or 2.0 M GST-Dhh1p.
(F) Dhh1p inhibited 48S preinitiation complex formation in vitro. Extracts were programmed with radiolabeled reporter and GMPPNP in the
presence or absence of 7.3 M GST-Dhh1p. Graph indicates percent of radiolabeled reporter in each fraction. Position of the RNP, 48S, and
80S complexes are indicated.from the encephalomycarditis (EMCV), hepatitis C (HCV),
and cricket paralysis (CrPV) viruses. Strikingly, we ob-
served that RCK/p54 inhibited translation from all three
IRES elements including CrPV IRES (Figure 5B), which
is known stimulate translation independent of all initia-
tion factors by binding directly to 40S and 60S ribo-
somal subunits (Wilson et al., 2000). Similar results
were seen for purified Dhh1p in reticulocyte extracts
(data not shown). Repression was specific to RCK/p54,
as purified Ded1p did not inhibit translation from IRES
constructs (data not shown). These results suggest
RCK/p54 and Dhh1p mediate translational repression
by acting directly on the mRNA itself or by impairing40S ribosome function. More importantly, these results
demonstrate that RCK/p54 and Dhh1p are general
translational repressors.
Translational Initiation Is Required
for Dhh1p Effects In Vivo
If Dhh1p is a translational repressor, then we predicted
that blocking translation by a strong stem-loop in the
5#UTR would bypass Dhh1p function in vivo (Muhlrad
et al., 1995). We observed that the PGK1mRNA bearing
a stem-loop in the 5#UTR (SL-PGK1) decays rapidly in
wild-type cells (t1/2 = 5.4#; Figure 6A). Importantly, de-
cay of the SL-PGK1 was not affected in dhh1D strains
Cell
882Figure 5. General Translational Inhibition by RCK/p54
LUC activity of various IRES-containing mRNAs in rabbit reticulo-
cyte lysate with 1 M, 2 M, or no recombinant RCK/p54. Activity
is normalized to translation in absence of RCK/p54. Identity of each
construct is indicated below graph, and corresponds to (A).
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m(t1/2 = 4.8#; Figure 6D). Similar results were seen with
other nontranslating substrates such as theMFA2 gene
with a 5#UTR stem-loop (data not shown). Since inhibi-
tion of translation in cis abrogates need for Dhh1p in
turnover, this provides an additional line of evidence
that Dhh1p functions as a translational repressor and
is not simply required for assembly of the decapping
complex per se. In contrast, we observed decreased
decay rates of the SL-PGK1 mRNA in lsm1D or pat1D
(t1/2 = 15# and 12#; Figures 6B and 6C). These data de-
monstrate that Dhh1p and Pat1p function in distinct
manners with Pat1p having an additional role in mRNA
decay separate from inhibition of translation. Because
Dhh1p and Pat1p show numerous physical interactions
with the decapping enzyme (Coller et al., 2001; Tharun
and Parker, 2001; Bonnerot et al., 2000), Pat1p’s sec-
ond role in mRNA turnover may be in helping to recruit
the decapping enzyme to mRNA. For Dhh1p, however,
recruitment of decapping enzyme by physical interac-
tions cannot be rate limiting for decapping to occur, as
WT decapping rates are seen for SL-PGK1 in dhh1D
mutants.
Discussion
Regulators of mRNA Decapping
Are Translational Repressors
Previous work has documented a reciprocal relation-
ship between mRNA translation and accumulation of
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wranscripts within P bodies, their decapping, and 5# to
# degradation. For example, mutations decreasing
ranslational initiation cause both an increase in decap-
ing rate and the production of P bodies (Schwartz and
arker, 1999, 2000; Teixeira et al., 2005). Conversely,
utations or conditions stabilizing mRNAs within the
olysome pool leads to a decrease in mRNA decapping
nd P body accumulation (Sheth and Parker, 2003;
eixeira et al., 2005). An unresolved issue has been to
etermine which proteins are involved in facilitating
ovement of mRNAs from polysomes into a transla-
ionally repressed mRNP that is capable of decapping
nd/or accumulation in P bodies.
Several observations now indicate that Dhh1p and
at1p are critical proteins that function in repressing
ranslation of mRNAs and facilitating formation of P
odies. First, while strains lacking either Dhh1p or
at1p show reductions in decapping rates and the abil-
ty to repress translation in response to glucose depri-
ation (Bonnerot et al., 2000; Coller et al., 2001; Fischer
nd Weis, 2002; Holmes et al., 2004), strains lacking
oth proteins are severely blocked for decapping, P
ody formation, and the ability to repress translation
Figures 1 and 2). Second, overexpression of either
at1p or Dhh1p inhibits growth, decreases polysomes,
nd drives P body accumulation (Figures 3A, 3B, and
D). Third, Dhh1p and its human homolog RCK/p54
unction as translation repressors in vitro (Figure 4D).
ourth, inhibiting translational initiation in cis bypasses
hh1p function in vivo (Figure 6). These results docu-
ent that Dhh1p and Pat1p, which had been charac-
erized as activators of the mRNA decapping reaction,
unction at least in part to repress translation and facili-
ate the transition in mRNP organization that leads to
RNAs being subject to decapping. One anticipates
hat other activators of decapping will also function by
nhibiting translation. For example, mRNAs targeted for
ecapping by nonsense-mediated decay are also
ranslationally repressed in a manner dependent upon
pf1p (Muhlrad and Parker, 1999), which suggests that
pf1p will act as a repressor of translation in some
anner.
There are two possible mechanisms by which Dhh1p
ight inhibit translation. In the simplest model, Dhh1p
ight promote the assembly of a translation repression
omplex, which sequesters the mRNA into an mRNP
hat is unable to be accessed by translation initiation
actors. Thus, translation repression occurs by se-
uestration of the mRNA away from the translation
achinery. Consistent with this hypothesis. Dhh1p ac-
umulates within P bodies in conjunction with transla-
ionally repressed mRNAs (Teixeira et al., 2005). Be-
ause Dhh1p is a member of the DEAD box family of
RNA-helicases,” Dhh1p could utilizes the energy of
TP hydrolysis, coupled with RNA binding, to create an
rreversible step in assembly that commits an mRNA
o the translationally repressed state. Such an mRNP
earrangement may facilitate further association and
ggregation of the repression complex, thereby creat-
ng a cascade of events that sequester the mRNA into
quiescent mRNP particle, such as a P body. Alterna-
ively, Dhh1p may interact with and inhibit the function
f a required translation factor. However, if Dhh1p
orks in this manner, its inhibition of 48S complex for-
A Mechanism of General Translational Repression
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tional Initiation In Vivo
Decay of SL-PGK1 reporter in (A) WT, (B)
lsm1D, (C) pat1D, and (D) dhh1D strains. Time
points are indicated above each lane. Half-
lives are indicated in minutes. Diagram indi-
cates position of the full-length mRNA and
polyguanosine decay intermediate. Poly(A) tail
lengths are determined by comparing mRNA
size to a oligo dT/RNaseH treated control (dT).mation on capped mRNAs and repression of translation
from the CrPV IRES, which bypasses the need for all
initiation factors, implies that it targets the 40S ribo-
somal subunit directly rather than a specific initiation
factor per se.
Several observations suggest the role of Dhh1p and
Pat1p in translational repression will be conserved in
eukaryotes cells, including mammalian. First, Dhh1p is
highly conserved protein and is 66% identical and 81%
similar between yeast and humans. Second, the human
homolog RCK/p54 represses translation in vitro similar
to Dhh1p (Figure 4D). Third, homologs of Dhh1p are re-
quired for translation repression events in Drosophila,
Xenopus, and C. elegans (Ladomery et al., 1997, Mins-
hall et al., 2001; Nakamura et al., 2001). Similarly, Pat1p
homologs in metazoans include the Xenopus protein,
P100 (Figure S6), which is also likely to participate in
the storage of maternal mRNAs (Murray et al., 1991;
Rother et al., 1992). Fourth, RCK/p54 accumulates
within P bodies in mammalian cells (Cougot et al.,
2004), and RCK/p54 knockdowns with siRNA reduce P
body formation (Andrei et al., 2005). Interestingly, inap-
propriate regulation of RCK/p54 expression has been
implicated in many types of tumors and in precancer-
ous conditions, such as hepatitis C infection (Naka-
gawa et al., 1999; Hashimoto et al., 2001; Miyaji et al.,2003). A clear implication of this conservation of func-
tion is that these alterations in mammalian cell physiol-
ogy associated with RCK/p54 are related to its role in
controlling translation and mRNA decay.
A General and Active Machinery
for Translational Repression
Several observations indicate that translational repres-
sion promoted by Dhh1p and Pat1p targets the majority
of cytoplasmic mRNA and functions in translational
control independent of mRNA degradation, both in
yeast and in other eukaryotes. First, decapping is the
predominant mRNA decay pathway in yeast, and all
normal mRNAs examined to date are affected by Dhh1p
and Pat1p (for review, see Coller and Parker, 2004).
Second, Dhh1p and/or Pat1p are required for global
translational repression in response to glucose depriva-
tion or amino acid starvation, wherein the vast majority
of mRNAs undergo translational repression (Figures 2B
and 2E). Third, overexpression of Dhh1p and Pat1p
leads to a dramatic decrease in global translation (Fig-
ures 2A–2C). Fourth, RCK/p54 represses translation of
all mRNAs tested in vitro indicating the effects are not
specific to the cap, poly(A) tail, or a specific initiation
step (Figures 4D and 5B). Thus, these results identify a
general mechanism of translational repression that can
Cell
884actively inhibit the translation of the majority of cyto-
plasmic mRNAs. Importantly, because Dhh1p and Pat1p
are required for the ongoing process of mRNA turnover
in normally growing cells, this repression mechanism is
constantly functioning and in competition with trans-
lation.
The presence of this active repression machinery
suggests that the status of translation, both globally
and on specific mRNAs, is due to the constant compe-
tition between the translational machinery and the re-
pression machinery (Figure 7). For example, in the ab-
sence of Dhh1p and Pat1p, global translation is only
marginally impaired by glucose deprivation or amino
acid starvation. This argues that the decrease in trans-
lation caused by these stresses is only sufficient to re-
press translation when there is a competing mecha-
nism to sequester the mRNAs in a repressed state
(Figures 1B and 1E). This suggests that the translation
and repression mechanisms are finely balanced, and
relatively subtle alterations in function of either may
have profound consequences for the distribution of
mRNAs between translation and repression.
The generality of Dhh1p and Pat1p translational re-
pression suggests that translation and decay are fun-
damentally coupled because the mode of translational
repression that accesses decapping is a major mode
of general translational repression. This provides an ex-
planation for the observation that numerous cis-acting
sequences controlling mRNA decay also affect trans-
lational repression. For example, the AU-rich destabil-
izing elements, referred to as AREs, often found in un-
stable metazoan mRNAs, can serve as translational
repression elements in some biological contexts (Otero
et al., 2001). Similarly, cis-acting elements in mRNAs
important for Drosophila development can modulate
both decay and translation (Sonoda and Wharton,
1999). A simple model is that some of these control
elements recruit translational repressors, possibly Dhh1p
or Pat1p, which then promote mRNAs exiting transla-
tion. Because there are clearly additional steps in the
decay pathway before decapping actually occurs, the
context of the translational repression could lead either
to translational repression and mRNA storage or to
c
o
a
w
T
c
s
s
g
a
p
p
b
b
B
t
s
q
m
c
e
b
m
X
r
C
m
m
M
t
s
m
s
s
m
p
i
c
t
C
TFigure 7. A General Active Repression Machinery Exists that Is in Competition with Translation
This competition creates a finely balanced system setting the relative translation rate for an mRNA. mRNAs can be driven into either transla-
tion or repression by tipping the balance of this competition via any number of events.mRNA degradation.The competition between assembly of a translation
omplex and repression suggests the translation rate
f individual mRNAs can be consequence of its relative
bility to either assemble translation factors or interact
ith various components of the repression machinery.
hus, an mRNP that effectively recruits the repression
omplex may strongly shift an mRNA into the repressed
tate. In addition, several observations suggest mRNA-
pecific repression complexes might feed into the
eneral repression system we have described. For ex-
mple, in Drosophila, the Oskar mRNA assembles a tri-
artite complex wherein eIF-4E is bound to the cap, but
revented from interaction with eIF-4G by the eIF-4E
inding protein Cup, which is delivered to the mRNA
y an interaction with the sequence specific binding of
runo to the 3# UTR (Nakamura et al., 2004). Despite
his repression complex, efficient translational repres-
ion of the Oskar mRNA during early development re-
uires the Drosophila homolog of Dhh1p, Me31b (Naka-
ura et al., 2001). Similarly, translation of Xenopus
yclin B1 mRNA is repressed by a tripartite complex of
IF-4E, maskin, which binds eIF-4E, and CPEB, which
inds to both the mRNA 3# UTR and to maskin (Grois-
an et al., 2000). Yet, CPEB interacts with Xp54, the
enopus homolog of Dhh1p, which might reinforce this
epression (Minshall et al., 2001; Nakahata et al., 2001).
onsistent with that view, overexpression of CPEB in
ammalian cells increases P bodies, and CPEB accu-
ulates within the P body foci (Wilczynska et al., 2005).
ore recently, the demonstration that mRNAs transla-
ionally repressed by miRNAs accumulate in P bodies
uggests that miRNA based translational repression
ight also interact with this general translation repres-
ion machinery (Liu et al., 2005). These interactions
uggest that mRNA-specific translational repression
echanisms might create an initial translationally re-
ressed mRNP, which then either directly or indirectly
nteracts with the general translational repression ma-
hinery to create a multilayered and robust system of
ranslational control.
onclusion
he general system of translational repression de-
scribed here provides a mechanistic understanding into
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885the interwoven nature of translation and mRNA decay.
Since movement of an mRNA into translational repres-
sion stimulates assembly of the decapping complex,
shifting the balance toward assembly of the transla-
tional repression complex will, in many cases, facilitate
removal of the mRNA from the cytoplasmic pool by de-
capping and thus maintain a linear movement of mRNA
from translation to repression to decay. In cases where
decapping is inhibited, either globally or in a mRNA-
specific manner, movement between translation and re-
pression might occur interchangeably and presumably
in a regulated fashion to control protein production.
Importantly, the presence of a general active mecha-
nism of translational repression implies the translation
status of a cytoplasmic mRNA is the consequence of a
constant competition between the translational appa-
ratus and the repression apparatus. This is analogous
to regulation of gene expression by alterations in chro-
matin states, where shifting DNA from chromatin to het-
erochromatin impacts transcription by driving and
maintaining active and inactive states. Analogously, the
general translational repression machinery we describe
creates an inactive mRNP state, with formation of a P
body being the ultimate manifestation of this event. The
key switch that stimulates the shift from translation to
repression could be any number of events, including
attenuation of the translational machinery, deadenyla-
tion, activation of the repression machinery, or specific
recruitment of the repression complex. While the re-
pression machinery may be ultimately what tips the
scale toward inactivation, it may be sequestration of
mRNA into a P body that, much like sequestration of
DNA into heterochromatin, maintains the repression
event, thereby limiting reentry of mRNA into translation.
Experimental Procedures
Yeast Strains, Plasmids, and Oligonucleotides
See Table S1.
RNA Analysis
Performed as in Coller et al. (2001). Cells with pRP485 (Figure S1)
or pRP543 (Figure 6), were grown in 2% gal, 1% suc media, har-
vested, and resuspended in 2% dex media. Following transcrip-
tional repression, aliquots were taken and RNA analyzed by PAGE
and Northern. For Figures 1C and 2C, RNA was analyzed by North-
ern blotting following polysome separation.
Polysome Analysis
Performed as described in Teixeira et al. (2005). Cyclohexamide
was omitted as it alters decapping and P bodies (Sheth and Parker,
2003). In Figures 1B and 1E, cells were grown in 2% dex media,
harvested, and resuspended in either media plus or minus dex (Fig-
ure 2B), or plus or minus amino acids (Figure 2E) and incubated for
10 min. In Figures 2A, 3B, and 3C, cells were grown in 2% suc
media, harvested, and resuspended in 2% suc or 2% gal media.
Cultures were incubated for 120 min. and then harvested. Figure
4F cells were grown in 2% dex media, and polysomes were ana-
lyzed using 7%–47% sucrose gradients. In Figure 4F, a 5%–25%
gradient was used.
In Vivo Labeling
[35S]methionine incorporation was performed as described in Ashe
et al. (2000).
Microscopy
For Figures 1A, 2A, 3B, 3C, and S3, P bodies were visualized with
pRP1175 (DCP2-GFP) or pRP1176 (LSM1-GFP). In Figure 1A, cells
were grown in 2% dex media until OD600 = 0.3. Cells were har-vested in media lacking glu and visualized by microscopy. In Fig-
ures 2A, 3B, and 3C, cells were grown to OD600 = 0.3 in 2% suc
media and resuspended in either 2% suc or 2% gal media and
visualized after 120 min.
Western Blot Analysis
Protein analysis was performed as described in Sheth and Parker
(2003), using anti-GFP antibody (Covance).
In Vitro Translation Assays
Performed as described in Ostareck et al. (2001). Purified GST-
Dhh1p or BSA (in 20 mM MES [pH 6.0], 200mM NaCl, 2mM DTT,
and 10% glycerol) was added to nuclease treated yeast extracts
made as in Iizuka and Sarnow (1997) or rabbit reticulocyte lysate
(Promega). In Figures 4A–4D, 250 ng of capped, poly(A)- LUC
mRNA was added to each reaction. Extracts were programmed
with 250 ng of capped or uncapped LUC mRNA (Figure 4E) or
250ng of IRES mRNA (Figure 5B). In Figure 4F, 1 g of radiolabeled,
capped, poly(A)- mRNA was used plus 0.5mM GMPPNP. Reactions
were assembled and incubated 1 hr at 30°C for retic or 22°C yeast
extract experiments. In Figures 4A–4E and 5B, LUC expression was
monitored using a LUC enzymatic assay (Promega). In Figure 4F,
translation was monitored by sucrose gradient, using a 5%–25%
gradient followed by Scintillation counting after fractionation.
Supplemental Data
Supplemental Data include six figures and a table and can be found
with this article online at http://www.cell.com/cgi/content/full/122/
6/875/DC1/.
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